Published

…further to the Pharmaceutical Price Regulation Scheme (PPRS) 2009

The NHS expects to be required to identify £15-20bn of efficiency savings by the end of the 2013-14 year in order to deliver improvements in quality of care. One of the areas in which the DH hopes to find savings is in spending on branded prescription medicines, which costs the NHS around £9bn a year.

As the number of prescriptions increased consistently over the last decade, this expenditure is expected to increase if no steps are taken to change the trend.

The Department of Health is working to target spending on pharmaceuticals through, among other initiatives, the Pharmaceutical Price Regulation Scheme (PPRS) 2009, a voluntary scheme negotiated between the DH and the Association of the British Pharmaceutical Industry (ABPI). The PPRS aims to reduce NHS expenditure on branded medicines by an average of 5% each year over the next five years. In addition to setting price levels for branded medicines, the PPRS makes provision for introducing generic substitution, subject to discussion with affected parties.

Our analysis of the Department of Health consultation on the proposals to implement ‘generic substitution’ in primary care has been published alongside an analysis of responses report authored by Greenstreet Berman Ltd for COI and the Department of Health.

 

You can view the report here (second link).